Welcome to Bladder Cancer
Clinical Trials Corner
Paper Alert
The management of upper tract urothelial cancer (UC) remains challenging; standard care being nep-hroureterectomy and bladder cuff excision (NU). However in the face of a...
Patients with metastatic (M1) Urothelial cancer (UC) have an extremely ominous prognosis, with a 5 year survival rate of <5% after receiving cisplatin- based combination...
Clinical Trials Corner
Paper Alert
The management of upper tract urothelial cancer (UC) remains challenging; standard care being nep-hroureterectomy and bladder cuff excision (NU). However in the face of a...
Patients with metastatic (M1) Urothelial cancer (UC) have an extremely ominous prognosis, with a 5 year survival rate of <5% after receiving cisplatin- based combination...
No front page content has been created yet.